Stockscreener 앱 받기
5.51
1.61%
-0.09
시간 외 거래:
5.45
-0.06
-1.09%
Precigen Inc 주식(PGEN)의 최신 뉴스
Precigen reports $3.4M in PAPZIMEOS sales for Q4 2025 - Investing.com
PGENPrecigen Inc Latest SEC Filings - Finviz
Precigen Insider Sold Shares Worth $2,042,864, According to a Recent SEC Filing - marketscreener.com
Precigen Insider Sold Shares Worth $1,113,143, According to a Recent SEC Filing - Moomoo
Precigen CFO Harry Thomasian Jr. sells $1.1m in company stock - Investing.com UK
Insider Sell Alert: Harry Thomasian Sells 200,000 Shares of Prec - GuruFocus
Precigen CEO Helen Sabzevari sells $2.04m in PGEN stock - Investing.com
Precigen COO Rutul Shah sells $251,105 in company stock - Investing.com
Precigen (PGEN) COO sells 42,924 shares after option exercise - Stock Titan
Precigen COO Rutul Shah sells $251,105 in company stock By Investing.com - Investing.com South Africa
Precigen CEO Helen Sabzevari sells $2.04m in PGEN stock By Investing.com - Investing.com India
[Form 4] PRECIGEN, INC. Insider Trading Activity - Stock Titan
Form 4 Precigen Inc For: 1 July By Investing.com - Investing.com Canada
Precigen (PGEN) CFO executes 200,000-share open-market sale under 10b5-1 plan - Stock Titan
Form 144 PRECIGEN For: 1 July By Investing.com - Investing.com Nigeria
PGEN (NASDAQ) affiliate files Rule 144 notice to sell 28,571 shares - Stock Titan
Does Precigen’s (PGEN) Russell Value Index Exit Signal a Shifting Investor Base or Story? - simplywall.st
[144] PRECIGEN, INC. SEC Filing - Stock Titan
Form 144 PRECIGEN For: 29 June By Investing.com - Investing.com South Africa
Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell 2000 Value Benchmark - marketscreener.com
Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell 2500 Value Benchmark - marketscreener.com
Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell 3000E Value Benchmark - marketscreener.com
Precigen: Entering The Oncology "Sweet Spot" (NASDAQ:PGEN) - Seeking Alpha
PGEN Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Precigen, Inc. – NASDAQ:PGEN - TradingView
Precigen Inc Actuals & Estimates (BX:I5X) - TradingView
Price to earnings forward of Precigen, Inc. – NASDAQ:PGEN - TradingView
Precigen Shareholders Expand Incentive Plan, Reaffirm Governance - The Globe and Mail
Precigen (PGEN) investors back 7M-share incentive pool and all board picks - Stock Titan
Clearfield And 2 Insider Picks For Strong Growth - simplywall.st
Precigen (PGEN) Is Up 12.1% After Orphan Exclusivity Win for PAPZIMEOS TherapyWhat's Changed - Sahm
Precigen stock hits 52-week high at 5.47 USD By Investing.com - Investing.com Australia
Precigen stock hits 52-week high at 5.47 USD - Investing.com
Precigen (PGEN) Ends 11.6% Higher — This FDA Approval Could Hold the Reason - Insider Monkey
Precigen Gains FDA Orphan Drug Exclusivity for Gene Therapy Candidate PAPZIMEOSDebt Analysis Report - Město Břeclav
Precigen (PGEN) Secures FDA Orphan Drug Exclusivity for PAPZIMEOS - Insider Monkey
PGEN News | PRECIGEN INC (NASDAQ:PGEN) - ChartMill
Precigen Inc (PGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PGEN: All proposals, including board elections and compensation, passed overwhelmingly without shareholder questions - TradingView
PGEN: All proposals, including board elections and compensation, passed overwhelmingly without dissent - TradingView
Precigen Inc Annual Shareholders Meeting Transcript - GuruFocus
Precigen Inc (PGEN) Institutional Confidence - TradingKey
Precigen Inc (PGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Precigen Inc (PGEN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Precigen Inc (PGEN) Valuation: PE, PB & Fair Value Analysis - TradingKey
1.18%
2.48%
자본화:
|
볼륨(24시간):